Sue Corringham

733 total citations
25 papers, 554 citations indexed

About

Sue Corringham is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Sue Corringham has authored 25 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Hematology and 5 papers in Immunology. Recurrent topics in Sue Corringham's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Sue Corringham is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Sue Corringham collaborates with scholars based in United States, United Kingdom and Vietnam. Sue Corringham's co-authors include Edward D. Ball, Asad Bashey, Ewa Carrier, Israel Lowy, Robert J. Soiffer, Bridget Medina, James R. Mason, Mildred Pasek, H. Kent Holland and Lawrence E. Morris and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Transfusion.

In The Last Decade

Sue Corringham

25 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sue Corringham United States	10	364	255	214	118	69	25	554
Mildred Pasek United States	4	309 0.8×	427 1.7×	377 1.8×	111 0.9×	54 0.8×	11	677
Bik To Australia	10	169 0.5×	127 0.5×	159 0.7×	91 0.8×	72 1.0×	18	424
JP Greer United States	6	265 0.7×	118 0.5×	151 0.7×	138 1.2×	87 1.3×	8	452
F. Dreyfus France	8	108 0.3×	166 0.7×	326 1.5×	68 0.6×	59 0.9×	18	453
Keiren Kirkland United Kingdom	11	162 0.4×	86 0.3×	297 1.4×	83 0.7×	84 1.2×	24	458
P Anderlini United States	8	177 0.5×	202 0.8×	552 2.6×	35 0.3×	70 1.0×	9	619
Minami Yamada Japan	12	134 0.4×	104 0.4×	154 0.7×	90 0.8×	77 1.1×	24	369
West Wh United States	10	165 0.5×	168 0.7×	88 0.4×	77 0.7×	39 0.6×	12	390
A M Huelskamp United States	8	177 0.5×	101 0.4×	253 1.2×	39 0.3×	48 0.7×	10	362
Mónica Cabrero Spain	11	93 0.3×	179 0.7×	382 1.8×	70 0.6×	145 2.1×	33	558

Countries citing papers authored by Sue Corringham

Since Specialization

Citations

This map shows the geographic impact of Sue Corringham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Corringham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Corringham more than expected).

Fields of papers citing papers by Sue Corringham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Corringham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Corringham. The network helps show where Sue Corringham may publish in the future.

Co-authorship network of co-authors of Sue Corringham

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Corringham. A scholar is included among the top collaborators of Sue Corringham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Corringham. Sue Corringham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holman, Peter, Caitlin Costello, Margarida Magalhaes‐Silverman, et al.. (2011). Idiotype Immunization Following High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 18(2). 257–264. 5 indexed citations

Drygalski, Annette von, Thuy B. Tran, Karen Messer, et al.. (2011). Obesity Is an Independent Predictor of Poor Survival in Metastatic Breast Cancer: Retrospective Analysis of a Patient Cohort Whose Treatment Included High-Dose Chemotherapy and Autologous Stem Cell Support. International Journal of Breast Cancer. 2011. 1–8. 32 indexed citations

Zhou, Jiehua, Asad Bashey, Sue Corringham, et al.. (2010). CTLA-4 Blockade following Relapse of Malignancy after Allogeneic Stem Cell Transplantation Is Associated with T Cell Activation But Not with Increased Levels of T Regulatory Cells. Biology of Blood and Marrow Transplantation. 17(5). 682–692. 52 indexed citations

Jung, A. Scott, Peter Holman, Januario E. Castro, et al.. (2009). Autologous Hematopoietic Stem Cell Transplantation as an Intensive Consolidation Therapy for Adult Patients in Remission from Acute Myelogenous Leukemia. Biology of Blood and Marrow Transplantation. 15(10). 1306–1313. 11 indexed citations

Trivedi, Meghana V., et al.. (2009). Optimal use of G-CSF administration after hematopoietic SCT. Bone Marrow Transplantation. 43(12). 895–908. 49 indexed citations

Medeiros, Bruno C., Sue Corringham, Steven Coutré, et al.. (2009). A Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies.. Blood. 114(22). 2049–2049. 1 indexed citations

Trivedi, Meghana V., et al.. (2009). Review and revision of clinical practice of using G-CSF after autologous and allogeneic hematopoietic stem cell transplantation at UCSD. Journal of Oncology Pharmacy Practice. 17(2). 85–90. 6 indexed citations

Bashey, Asad, Bridget Medina, Sue Corringham, et al.. (2008). CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation. Blood. 113(7). 1581–1588. 270 indexed citations

Bashey, Asad, Michael Donohue, Lin Liu, et al.. (2007). Peripheral blood progenitor cell mobilization with intermediate‐dose cyclophosphamide, sequential granulocyte‐macrophage–colony‐stimulating factor and granulocyte–colony‐stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation. Transfusion. 47(11). 2153–2160. 13 indexed citations

10.

Bashey, Asad, Bridget Medina, Sue Corringham, et al.. (2007). Clinical Trial of Therapeutic Blockade of CTLA4 with Ipilimumab in Patients with Relapse of Malignancy Following Allogeneic Hematopoietic Transplantation.. Blood. 110(11). 1646–1646. 2 indexed citations

11.

Bashey, Asad, Bridget Medina, Sue Corringham, et al.. (2006). Phase I Study of Ipilimumab (Neutralizing Monoclonal Anti-CTLA4 Antibody) To Treat Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation: Evidence of Tumor Regression without Induction of GVHD.. Blood. 108(11). 410–410. 1 indexed citations

12.

Bashey, Asad, Bridget Medina, Jiehua Zhou, et al.. (2005). Phase I study of a neutralizing monoclonal anti-CTLA4 antibody (MDX-010) in patients with relapse of malignancy after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 11(2). 5–5. 2 indexed citations

13.

Bashey, Asad, Lin Liu, Bridget Medina, et al.. (2005). Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older. Leukemia Research. 30(4). 503–506. 12 indexed citations

14.

Bashey, Asad, Oralia Loza, Bridget Medina, et al.. (2005). BEAM Versus CEB Conditioning for Autologous Transplantation in Patients with Non-Hodgkin’s Lymphoma and Hodgkin’s Disease: A Single Center Comparative Study of 219 Patients.. Blood. 106(11). 2079–2079. 1 indexed citations

15.

Bashey, Asad, Bridget Medina, Sue Corringham, et al.. (2005). Phase I Study of a Neutralizing Monoclonal Anti-CTLA4 Antibody (MDX-010) in Patients with Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation.. Blood. 106(11). 2017–2017. 2 indexed citations

16.

Corringham, Sue, et al.. (2004). High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma. Bone Marrow Transplantation. 34(7). 581–587. 44 indexed citations

17.

Bashey, Asad, Suchitra Sundaram, Sue Corringham, et al.. (2001). Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High- Dose Chemotherapy and Autologous Stem Cell Support. Clinical Oncology. 13(6). 434–437. 5 indexed citations

18.

Bashey, Asad, et al.. (2000). A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle. Bone Marrow Transplantation. 25(5). 519–524. 9 indexed citations

19.

Bashey, Asad, Sue Corringham, Karen K. Fields, et al.. (2000). Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantation. Cytotherapy. 2(3). 195–200. 16 indexed citations

20.

Vincent, Mark, Glen Goss, Clive Sinoff, et al.. (1994). Bi-weekly vincristine, epirubicin and methylprednisolone in alkylator-refractory multiple myeloma. Cancer Chemotherapy and Pharmacology. 34(4). 356–360. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact